Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.

ABSTRACT: Comprehensive knowledge of the genomic alterations that underlie cancer is a critical foundation for diagnostics, prognostics, and targeted therapeutics. Systematic efforts to analyze cancer genomes are underway, but the analysis is hampered by the lack of a statistical framework to distinguish meaningful events from random background aberrations. Here we describe a systematic method, called Genomic Identification of Significant Targets in Cancer (GISTIC), designed for analyzing chromosomal aberrations in cancer. We use it to study chromosomal aberrations in 141 gliomas and compare the results with two prior studies. Traditional methods highlight hundreds of altered regions with little concordance between studies. The new approach reveals a highly concordant picture involving approximately

SUBMITTER: Beroukhim R 

PROVIDER: S-EPMC2148413 | biostudies-literature | 2007 Dec

REPOSITORIES: biostudies-literature